Daiwa Securities Upgrades Edwards Lifesciences Outperform From Neutral, Adjusts Price Target to $72 From $87
Daiwa Securities Upgrades Edwards Lifesciences Outperform From Neutral, Adjusts Price Target to $72 From $87
大和證券將愛德華生命科學評級由中立升級爲跑贏大盤，並將目標股價從87美元調整爲72美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊